Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suoming Zhang

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
1H-Pyrazolo-[3,4-c]cyclophepta[1,2-c]thiophenes: a unique structural class of dopamine D4 selective ligandsAndrew Thurkauf, Xi Chen, Suoming Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine proteaseMaosheng Duan, Wieslaw Kazmierski, Renae Crosby, et al.
Bioorganic & Medicinal Chemistry Letters|November 12, 2010
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 proteaseCharles Z Ding, Yong-Kang Zhang, Xianfeng Li, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2010
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 proteaseXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groupsXianfeng Li, Yang Liu, Yong-Kang Zhang, et al.
Journal of Medicinal Chemistry|April 5, 2012
Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutantsWieslaw M Kazmierski, Robert Hamatake, Maosheng Duan, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moietiesXianfeng Li, Suoming Zhang, Yong-Kang Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronatesXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA SynthetaseAndrés Palencia, Xianfeng Li, Wei Bu, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
1H-Pyrazolo-[3,4-c]cyclophepta[1,2-c]thiophenes: a unique structural class of dopamine D4 selective ligandsAndrew Thurkauf, Xi Chen, Suoming Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine proteaseMaosheng Duan, Wieslaw Kazmierski, Renae Crosby, et al.
Bioorganic & Medicinal Chemistry Letters|November 12, 2010
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 proteaseCharles Z Ding, Yong-Kang Zhang, Xianfeng Li, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2010
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 proteaseXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groupsXianfeng Li, Yang Liu, Yong-Kang Zhang, et al.
Journal of Medicinal Chemistry|April 5, 2012
Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutantsWieslaw M Kazmierski, Robert Hamatake, Maosheng Duan, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moietiesXianfeng Li, Suoming Zhang, Yong-Kang Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronatesXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA SynthetaseAndrés Palencia, Xianfeng Li, Wei Bu, et al.
Pageof 2